"Thai Deputy Defense Minister Condemns Cambodia Over Landmine Incident Injuring Thai Soldiers; Keo Remy, however, warned, 'Please do not walk like a crab.'" | BREAKING: Tensions Escalate: Thai Troops Prepare to Launch Unauthorized Attack on Cambodian Territory Amid Internal Political Strife | Cambodia Rebuts Thailand’s Baseless Landmine Allegations and Urges Diplomacy to Maintain Regional Peace | Cambodia Accuses Thailand of Using Landmine Incidents as a Political Tool and Violating Ceasefire Agreements | Breaking: Kandal Provincial Police Arrest Notorious Lotion Manufacturer Love Riya | Cambodia Clarifies Misleading Claims About Ottawa Convention Meeting in Bangkok | Cambodia, China, and Thailand Discuss Regional Cooperation and Border Disputes at Mekong-Lancang Meeting | Smile Asia Philanthropic Visionary Award” Presented to Dr. Pich Chanmony Hun Manet | Cambodia & Thailand Call for Restraint and Adherence to International Agreements | International Observer Team Conducts Monitoring Visit Following Cambodia–Thailand Ceasefire Agreement | Cambodia, Vietnam Strengthen Ties in High‑Level Video Conference; Aim for $20B Trade |

Biden Signs Bill that Accelerates Research for Major Illnesses Like ALS

INTERNATIONAL: U.S President Joe Biden on Thursday has signed into law the "Accelerating Access to Critical Therapies for ALS Act" which fast-tracks funding for research of degenerative neurological diseases such as amyotrophic lateral sclerosis (ALS).

"For too long, there have been no survivors of ALS but this bill could get us closer to changing that," Biden has said during the virtual signing ceremony from the White House.

The Act requires the U.S. Department of Health and Human Services to create grant programs, a public-private partnership, and an action plan for the study of ALS and other neurodegenerative diseases, including investigational drugs, the White House said on its website.

Biden has said the law invests $100 million annually for the next five years to help reach its goals. He also said he will call for the creation of a government research agency to advance breakthroughs in other neurological diseases such as cancer, diabetes and Alzheimer's.



Related News